Trials / Unknown
UnknownNCT02541110
Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler
Second Trimester Maternal Serum Homocysteine Level & Uterine Artery Doppler for Prediction of Preeclampsia , Intra-Uterine Growth Retardation (IUGR) & Other Obstetric Complications
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Kasr El Aini Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Second trimester homocysteine \& uterine artery doppler will be assessed\& the cases will be followed up till delivery for development of preeclampsia, IUGR(intra-uterine growth retardation) \& other obstetric complications.
Detailed description
Spontaneous pregnancies with no risk factors will be included. Fasting plasma total homocysteine level samples will be collected between 15th \& 19th weeks. Uterine artery doppler between 18th \& 22nd weeks. Method 1: Screen positive cases will be considered if homocysteine level above 6.3umol/l Method 2: Screen positive cases will be considered if they had bilateral notches and a mean resistivity index (RI) above 0.55, or unilateral notches and a mean RI above 0.65, or absence of notches and a mean RI above 0.7. Method 3: Screen positive cases will be considered if they had bilateral notches and a mean RI above 0.55, or unilateral notches and a mean RI above 0.65, or absence of notches and a mean RI above 0.7 combined with homocysteine cut off value of 6.3umol / l.
Conditions
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-01-01
- Completion
- 2016-02-01
- First posted
- 2015-09-04
- Last updated
- 2015-09-04
Source: ClinicalTrials.gov record NCT02541110. Inclusion in this directory is not an endorsement.